News Snapshot:
NewsDesk JAKARTA – With the slow development of phase three clinical trials for the Covid-19 vaccine candidate, Indonesia said it had requested data from Brazil, where similar trials were running smoothly. It is expected to receive safety and efficacy data on Chinese company Sinovac Biotech CoronaVac on December 28, and hopes to finally start rolling out a vaccination program in January. The third phase clinical trial is the final stage a vaccine candidate must complete before it is licensed for use by regulatory agencies in the country concerned. The BPOM, the equivalent of the US Food and Drug Administration, has...
